Steven Cohen Ascendis Pharma A/S Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 569,146 shares of ASND stock, worth $101 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
569,146
Previous 503,669
13.0%
Holding current value
$101 Million
Previous $69.3 Million
27.93%
% of portfolio
0.22%
Previous 0.16%
Shares
14 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.83 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$973 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$926 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$797 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$756 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.91B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...